If you ever shopped at the discounted store, Dollar Tree, to get your hands on some uber cheap goods, you will want to listen up. While their over the counter drug section is so perfectly priced, which can seem too good to be true, we're now finding out that it is.
We understand it's cold season. Which means that we're all stocking up on everything we could possibly need, so we aren't running out in the cold; to grab our prefered cold meds whenever we feel under the weather. But if the Dollar Tree is one of your favorite places to shop, you might want to think again before hitting them up this season.
Earlier this month, the US Food and Drug Administration (FDA) has issued a warning to Dollar Tree for selling over-the-counter drugs produced by foreign manufacturers who have been found to be unsafe. The letter was sent to Greenbrier International Inc., who does business as Dollar Tree. It outlined, that the adulterated drugs being received from manufacturers and suppliers who also received separate FDA warning letters last year, were placed on "import alert."
It also reveals there have been multiple manufacturing violations from those contracted manufacturers. They produce Dollar Tree's over-the-counter drugs, Assured, as well as other drug products sold at Dollar Tree and Family Dollar stores. This is something to which we should all pay close attention.
So, what is the FDA's resolution? In the letter, they have asked that Dollar Tree implements a system that will ensure them and their customers that they are not importing any adulterated drugs.
Donald D. Ashley, director of the Office of Compliance in the FDA's Center for Drug Evaluation and Research, said in a news release on Thursday, "Americans expect and deserve drugs that are safe, effective and that meet our standards for quality. The importation and distribution of drugs and other products from manufacturers that violate federal law is unacceptable."
"In this case, Dollar Tree has the ultimate responsibility to ensure that it does not sell potentially unsafe drugs and other FDA-regulated products to Americans," he said. "We will remain vigilant in our efforts to protect the U.S. public from companies who put the health of Americans at risk -- whether through the manufacturing and distribution of products we regulate or other means."
The Dollar Tree's response came on Thursday from Randy Guiler, Vice President of investor relations at Dollar Tree saying, "We are committed to our customers' safety and have very robust and rigorous testing programs in place to ensure our third-party manufacturers' products are safe." Furthermore, "Each of the items referenced in the report are topical, and not ingestible, products. As always, we are cooperating with the US Food and Drug Administration (FDA). We plan to meet with the FDA in the near future and expect that our plans will satisfy their requirements in all regards," the statement said. The Dollar Tree has fifteen days to respond to the FDA in writing.